SAN ANTONIO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- A new analysis by Verify Markets shows the U.S. pacemaker market was valued over $1.7 billion in 2020 and is expected to witness a steady growth rate during the forecast period. The market is likely to be driven by a growing aging population, rising prevalence of cardiovascular and chronic diseases, and technological advances in pacemaker designs that reduce risk and discomfort. Some examples include the development of leadless pacemakers and MRI-compatible pacemakers. Artificial intelligence techniques have a potential to increase accuracy, reliability, and reduce errors in diagnostic methods, which are likely to help in early diagnosis and implementation of cost-effective treatments for cardiovascular diseases. Pacemakers are increasingly being designed to reduce patient discomfort and are equipped with long lasting batteries and remote accessibility.